epicatechin gallate has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, JA; Li, J; Li, Y; Lin, Y; Liu, Z; Zhang, X | 1 |
| Isemura, M; Mukae, N; Narumi, K; Nukiwa, T; Ogata, K; Satoh, K; Suzuki, Y | 1 |
2 other study(ies) available for epicatechin gallate and B16 Melanoma
| Article | Year |
|---|---|
Anti-melanogenic effects of epigallocatechin-3-gallate (EGCG), epicatechin-3-gallate (ECG) and gallocatechin-3-gallate (GCG) via down-regulation of cAMP/CREB /MITF signaling pathway in B16F10 melanoma cells.
Topics: Animals; Catechin; Cell Line, Tumor; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Down-Regulation; Melanins; Melanoma, Experimental; Mice; Microphthalmia-Associated Transcription Factor; Molecular Structure; Monophenol Monooxygenase; Signal Transduction; Tea | 2020 |
Effects of catechins on the mouse tumor cell adhesion to fibronectin.
Topics: Animals; Binding Sites; Catechin; Cell Adhesion; Fibronectins; Lung Neoplasms; Melanoma, Experimental; Mice; Tumor Cells, Cultured | 1995 |